Sientra Inc
Change company Symbol lookup
Select an option...
SIEN Sientra Inc
PMGM Priveterra Acquisition Corp
NVFY Nova LifeStyle Inc
GGIFF Garibaldi Resources Corp
MIGI Mawson Infrastructure Group Inc
GTIM Good Times Restaurants Inc
BENF Avalon Acquisition Inc
SOS Sos Ltd
HOFV Hall of Fame Resort & Entertainment Co
SCVL Shoe Carnival Inc

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

Sientra, Inc. is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.

Day's Change
1.15 (65.71%)
B/A Size
Day's High
Day's Low
(Heavy Day)

Today's volume of 33,137,654 shares is on pace to be much greater than SIEN's 10-day average volume of 363,878 shares.


AppLovin stock set to recover more than $1 billion of its vanished valuation after strong forecast

8:27 am ET February 9, 2023 (MarketWatch)

By Wallace Witkowski

AppLovin shares rise nearly 30% in after-hours trading as execs predict 'relatively stable' mobile-ad market and project revenue growth, while still looking to sell apps business

AppLovin Corp. was set to recover more than $1 billion of its collapsed valuation after a strong forecast in a questionable mobile-ad market Wednesday.

AppLovin (APP) shares soared nearly 30% during the after-hours trading period after the company forecast revenue higher than Wall Street estimates. The stock move was not equal to the forecast beat -- $685 million to $705 million in revenue vs. $681.5 million forecast by analysts surveyed by FactSet -- but revenue growth of more than 10% year-over-year stood out after AppLovin's revenue grew less than 1% in 2022.

"For the first quarter of 2023, we see the mobile ad market remaining relatively stable," the company initially said in a letter to shareholders. "Developers continue to closely monitor their overall profitability and advertisers appear to be maintaining overall ad budgets and return on ad spend goals, informing our outlook for the quarter."

Read:'Call of Duty' may need to spin off from Activision for approval of Microsoft deal

AppLovin was worth more than $40 billion at its pandemic peak, but the stock has cratered 82% in the past 12 months, as Applovin attempted a $20 billion acquisition of rival Unity Software Inc. (U) and failed. Unity's stock, down 66%, also received an after-hours updraft of more than 6% Wednesday. In comparison, the S&P 500 index fell 9% over the past 12 months, while the and a nearly 18% fall on the tech-heavy Nasdaq Composite Index fell nearly 18%.

Co-founder and Chief Executive Adam Foroughi told analysts AppLovin was investing to upgrade its proprietary Axon machine-learning recommendation engine with advances in artificial intelligence, or AI.

From 2021: 5 things to know about AppLovin

"There's been huge advancements in AI technologies, and we're working on bringing those to our core platform," Foroughi said. "Advertising is immensely competitive. There's a lot of players that are trying to get ad dollars from advertisers, and trying to build algorithms to help those advertisers market themselves."

For instance, Unity spent 2022 recovering from a disclosure in May that its Operate Solutions ad-targeting tools -- the same tools that had been credited with finding a workaround to Apple Inc.'s (AAPL) opt-out of using Identifier for Advertisers, or IDFA -- contained a flaw.

"What we do know about our sector is that if algorithms improve, if targeting can get back to pre-IDFA levels, the category was growing almost double digits every single year consistently for a decade," Foroughi said.

AppLovin noted it had $1.1 billion on its balance sheet at the end of 2022 for "key projects, strategic acquisitions, and share repurchases." On the call, AppLovin Chief Financial Officer Herald Chen told analysts the company will "think carefully about capital allocation."

AppLovin's software helps app developers monetize through advertising, but it also has an apps business it manages like a standalone concern, and has sought to sell. AppLovin said it could still sell its app business, but in the meantime, it was comprised of "11 studios plus several publishing relationships that we believe can collectively increase enterprise value over time."

Read: There is a 'new normal' in the videogame industry, and Wall Street is still adapting

AppLovin topped Wall Street estimates for both of its segments in the fourth quarter. The company said that software revenue rose 24% to $306 million, while apps revenue fell 28% to $396 million. Analysts had expected $303.1 million in software revenue, and $313 million app revenue. For the fourth quarter, AppLovin reported an adjusted margins, however, improved for apps (19% versus 8% a year ago), but declined for software, 61% versus 71% a year ago.

AppLovin reported a fourth-quarter loss of $79.5 million, or 21 cents a share, versus net income of $31.1 million, or 8 cents a share, in the year-ago period.The company did not list adjusted earnings per share figures. Revenue fell to $702.3 million from $793.5 million in the year-ago quarter. Analysts had forecast earnings of 5 cents a share on revenue of $690.4 million.

-Wallace Witkowski


(END) Dow Jones Newswires

February 09, 2023 08:27 ET (13:27 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.